OwlBrief

Stay informed, stay wise!

OwlBrief gives busy professionals the world’s top stories in seconds — five ultra-fast, AI-crafted briefs a day. Stay informed, stay wise, and never waste time on fluff.

Create account Log in

Pharma & Biotech

UK’s FTSE 100 share index closes at record high as AstraZeneca becomes London’s biggest stock again – as it happened

The FTSE 100 index closed at a record high of 9446 points, driven by AstraZeneca's surge and relief over potential tariff impacts on the pharma sector.

Exclusive: Electroflow promises to make LFP material for 40% less than Chinese producers

Electroflow plans to produce lithium-iron-phosphate batteries at 40% lower costs than Chinese manufacturers, aiming to establish a domestic supply chain in the U.S.

Regeneron drug reduces errant bone growth in ultra-rare skeletal condition

Regeneron's garetosmab shows promise in treating fibrodysplasia ossificans progressiva, a rare condition causing abnormal bone growth, with regulatory submissions planned.

Trump, Chinese biotech, and an industry career reshaped by illness

In the latest episode of 'The Readout LOUD,' hosts discuss a personal essay by pharma consultant Mike Rea on how illness reshaped his career. They also explore President Trump's consideration of a crackdown on drugs developed in China,...